Cellular Mechanisms of Aggregation of Abnormal Proteins

异常蛋白质聚集的细胞机制

基本信息

  • 批准号:
    8034757
  • 负责人:
  • 金额:
    $ 38.1万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2004
  • 资助国家:
    美国
  • 起止时间:
    2004-07-01 至 2013-02-28
  • 项目状态:
    已结题

项目摘要

DESCRIPTION (provided by applicant): Failure of the ubiquitin proteasome machinery and molecular chaperones may result in aggregation of mutant or damaged polypeptides leading to various devastating diseases. However, special molecular machinery has evolved as a last line of defense to relieve proteotoxicity by transporting misfolded protein aggregates/oligomers to the centrosome-localized aggresome. The main objective of this proposal is to uncover the mechanisms of aggresome formation. The proposed work is based on our yeast model of aggregation of proteins with expanded polyglutamine (polyQ) domains. In the past, this model was used to identify small molecules that suppress polyQ aggregation, improve motor performance and reduce neuronal atrophy in a mouse model of HD. With this model, we have established that (a) aggresome formation both in yeast and mammalian cells requires transferable aggresome-targeting signals on substrate proteins, e.g. the proline-rich region (P-region) of exon 1 of huntingtin, (b) an SH3-domain protein Boi2 serves as a recognition element for the P-region aggresome- targeting signal, (c) a yeast 14-3-3 protein Bmh1 and components of the Cdc48/VCP-Ufd1-Nlp4 complex play an essential role in aggresome formation. We also established a cell culture model of aggresome formation to investigate the relevance for mammalian cells of aggresome components identified in yeast. In Aim 1 we will clarify how the aggresome machinery recognizes small polyQ aggregates/oligomers. We will establish the role of the SH3-domain protein Boi2 in the recognition of the aggregates in yeast, and will clarify whether Boi2 homologs function in mammalian cells to recognize huntingtin and other polyQ-containing pathological proteins. In Aim 2 we will establish the function of the 14-3-3 protein Bmh1 in early stages of aggresome formation in yeast, and will test whether 14-3-3 proteins play a general role in aggresome formation in mammalian cells. These experiments will help to clarify how the aggresome machinery distinguishes small aggregates/oligomers of abnormal polypeptides from soluble monomers. In Aim 3 using both biochemical and genetic approaches we will identify novel components involved in aggresome formation. As a result of this work, we plan to obtain sufficient information for understanding the mechanism of aggresome formation. PUBLIC HEALTH RELEVANCE Many devastating diseases, including major neurodegenerative disorders, are caused by accumulation of abnormal proteins. These abnormal species tend to aggregate, and here we will establish cellular mechanisms of protein aggregation. This work will uncover how organisms try to protect themselves from development of Hungtington's and certain other diseases.
描述(由申请人提供):泛素蛋白酶体机制和分子伴侣的失效可能导致突变或受损多肽的聚集,从而导致各种破坏性疾病。然而,特殊的分子机制已经发展成为最后一道防线,通过将错误折叠的蛋白质聚集体/寡聚体转运到中心体定位的攻击体来减轻蛋白毒性。该建议的主要目的是揭示侵略形成的机制。所提出的工作是基于我们的酵母模型的蛋白质与扩展的聚谷氨酰胺(polyQ)结构域的聚集。在过去,该模型被用于在HD小鼠模型中鉴定抑制polyQ聚集、改善运动性能和减少神经元萎缩的小分子。利用该模型,我们已经确定(a)酵母和哺乳动物细胞中的攻击基因组形成需要底物蛋白上的可转移的攻击基因组靶向信号,例如富含脯氨酸的区域(B)SH 3结构域蛋白Boi 2用作P区攻击基因组靶向信号的识别元件,(c)酵母14-3-3蛋白Bmh 1和Cdc 48/VCP-Ufd 1-Nlp 4复合物的组分在侵袭基因组形成中起重要作用。我们还建立了一个细胞培养模型的侵略形成调查的相关性为哺乳动物细胞的侵略组件中鉴定的酵母。在目标1中,我们将阐明攻击组机制如何识别小的polyQ聚集体/寡聚体。我们将建立SH 3结构域蛋白Boi 2在酵母中识别聚集体的作用,并将澄清Boi 2同系物是否在哺乳动物细胞中起识别亨廷顿蛋白和其他含polyQ的病理蛋白的作用。在目标2中,我们将确定14-3-3蛋白Bmh 1在酵母中侵袭基因组形成的早期阶段的功能,并将测试14-3-3蛋白是否在哺乳动物细胞中侵袭基因组形成中发挥一般作用。这些实验将有助于阐明攻击组机制如何区分异常多肽的小聚集体/寡聚体与可溶性单体。在目标3中,使用生物化学和遗传方法,我们将鉴定出参与攻击体形成的新组分。作为这项工作的结果,我们计划获得足够的信息,了解侵略形成的机制。许多破坏性疾病,包括主要的神经退行性疾病,都是由异常蛋白质的积累引起的。这些异常的种类倾向于聚集,在这里,我们将建立蛋白质聚集的细胞机制。这项工作将揭示生物体如何试图保护自己免受亨廷顿病和某些其他疾病的发展。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Michael Y Sherman其他文献

Michael Y Sherman的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Michael Y Sherman', 18)}}的其他基金

Age Dependence of Breast Cancer
乳腺癌的年龄依赖性
  • 批准号:
    8570537
  • 财政年份:
    2013
  • 资助金额:
    $ 38.1万
  • 项目类别:
Age Dependence of Breast Cancer
乳腺癌的年龄依赖性
  • 批准号:
    8668909
  • 财政年份:
    2013
  • 资助金额:
    $ 38.1万
  • 项目类别:
CHARACTERIZATION OF HUNTINGTON AND PARKINSON AGGREGATES BY MASS SPECTROMETRY
通过质谱法表征亨廷顿和帕金森聚集体
  • 批准号:
    8365536
  • 财政年份:
    2011
  • 资助金额:
    $ 38.1万
  • 项目类别:
CHARACTERIZATION OF POLYGLUTAMINE AGGREGATES BY MASS SPECTROMETRY
通过质谱法表征聚谷氨酰胺聚集体
  • 批准号:
    8170904
  • 财政年份:
    2010
  • 资助金额:
    $ 38.1万
  • 项目类别:
CHARACTERIZATION OF POLYGLUTAMINE AGGREGATES BY MASS SPECTROMETRY
通过质谱法表征聚谷氨酰胺聚集体
  • 批准号:
    7955936
  • 财政年份:
    2009
  • 资助金额:
    $ 38.1万
  • 项目类别:
Suppression of the heat shock response in aging and neurodegeneration
抑制衰老和神经退行性疾病中的热休克反应
  • 批准号:
    7512138
  • 财政年份:
    2008
  • 资助金额:
    $ 38.1万
  • 项目类别:
CHARACTERIZATION OF POLYGLUTAMINE AGGREGATES BY MASS SPECTROMETRY
通过质谱法表征聚谷氨酰胺聚集体
  • 批准号:
    7723036
  • 财政年份:
    2008
  • 资助金额:
    $ 38.1万
  • 项目类别:
Suppression of the heat shock response in aging and neurodegeneration
抑制衰老和神经退行性疾病中的热休克反应
  • 批准号:
    7668382
  • 财政年份:
    2008
  • 资助金额:
    $ 38.1万
  • 项目类别:
CHARACTERIZATION OF POLYGLUTAMINE AGGREGATES BY MASS SPECTROMETRY
通过质谱法表征聚谷氨酰胺聚集体
  • 批准号:
    7602030
  • 财政年份:
    2007
  • 资助金额:
    $ 38.1万
  • 项目类别:
Cell Mechanisms of Abnormal Protein Aggregation
蛋白质异常聚集的细胞机制
  • 批准号:
    7271879
  • 财政年份:
    2004
  • 资助金额:
    $ 38.1万
  • 项目类别:

相似海外基金

Progression of Early Atrophic Lesions in Age-related Macular degeneration
年龄相关性黄斑变性早期萎缩性病变的进展
  • 批准号:
    10635325
  • 财政年份:
    2023
  • 资助金额:
    $ 38.1万
  • 项目类别:
In vivo Identification of Pre-Atrophic Brain Neurodegeneration in Prodromal Alzheimer Disease with Quantitative Gradient Recalled Echo MRI
利用定量梯度回忆回波 MRI 体内鉴定阿尔茨海默病前驱期的萎缩前脑神经变性
  • 批准号:
    10448152
  • 财政年份:
    2022
  • 资助金额:
    $ 38.1万
  • 项目类别:
The Development and Rescue of an Atrophic Nonunion Model
萎缩性骨不连模型的开发和挽救
  • 批准号:
    10007577
  • 财政年份:
    2019
  • 资助金额:
    $ 38.1万
  • 项目类别:
The Development and Rescue of an Atrophic Nonunion Model
萎缩性骨不连模型的开发和挽救
  • 批准号:
    10242918
  • 财政年份:
    2019
  • 资助金额:
    $ 38.1万
  • 项目类别:
Analysis of the role of AMPK in the retina for the development of a novel treatment for atrophic age-related macular degeneration
分析 AMPK 在视网膜中的作用,以开发治疗萎缩性年龄相关性黄斑变性的新方法
  • 批准号:
    18K09457
  • 财政年份:
    2018
  • 资助金额:
    $ 38.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Regeneration of atrophic salivary glands by reconstructing tissue macrophages using amniotic fluid-derived cells
利用羊水来源的细胞重建组织巨噬细胞来再生萎缩的唾液腺
  • 批准号:
    19K21370
  • 财政年份:
    2018
  • 资助金额:
    $ 38.1万
  • 项目类别:
    Grant-in-Aid for Research Activity Start-up
The study to detect early-stage pancreatic cancer based on the data from molecular biology about the atrophic acinar cell surrounding carcinoma in situ.
该研究基于原位癌周围萎缩性腺泡细胞的分子生物学数据来检测早期胰腺癌。
  • 批准号:
    18K07897
  • 财政年份:
    2018
  • 资助金额:
    $ 38.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (C)
Multiple control and visualization of self-somatic- stem cells for atrophic jaw bone augmentation
用于萎缩颌骨增量的自体干细胞的多重控制和可视化
  • 批准号:
    17H04394
  • 财政年份:
    2017
  • 资助金额:
    $ 38.1万
  • 项目类别:
    Grant-in-Aid for Scientific Research (B)
Delivery of concentrated peripheral blood derived EPCs and functional miRNAs for atrophic salivary gland regeneration
输送浓缩的外周血来源的 EPC 和功能性 miRNA 以促进萎缩唾液腺再生
  • 批准号:
    17K17272
  • 财政年份:
    2017
  • 资助金额:
    $ 38.1万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
Development of novel oligonucleotide therapeutics using functional liposomes for atrophic muscular disorder
使用功能性脂质体开发治疗萎缩性肌肉疾病的新型寡核苷酸疗法
  • 批准号:
    16K20646
  • 财政年份:
    2016
  • 资助金额:
    $ 38.1万
  • 项目类别:
    Grant-in-Aid for Young Scientists (B)
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了